Estimating the magnitude of colorectal cancers prevented during the era of screening 1976 to 2009

Cancer

Volumn 120, Issue 18, 2014, Pages 2893-2901

  Yang, Daniel X ^a,b   Gross, Cary P ^a,b   Soulos, Pamela R ^a,b   Yu, James B ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b and Effectiveness Research ^*  (United States)

Author keywords

Cancer screening; Colonoscopy; Colorectal neoplasms; Incidence; Neoplasms

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; EARLY CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; TREND STUDY; CANCER REGISTRY; COLORECTAL TUMOR; EARLY DIAGNOSIS; FOLLOW UP; INCIDENCE; MIDDLE AGED; NEOPLASM; PROGNOSIS; STATISTICS; TIME; UNITED STATES;

CANCER SCREENING; COLONOSCOPY; COLORECTAL NEOPLASMS; INCIDENCE; NEOPLASMS;

ADULT; COLONOSCOPY; COLORECTAL NEOPLASMS; CONNECTICUT; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM; TIME FACTORS;

EID: 84908031556     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28794     Document Type: Article

References (40)

1. Brawley OW, Kramer BS. Cancer screening in theory and in practice. J Clin Oncol. 2005;23:293-300.
2. Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol. 2010;37:202-215.
3. Esserman LJ, Thompson IM Jr, Reid B. Over diagnosis and over-treatment in cancer: an opportunity for improvement. JAMA. 2013; 310:797-798.
4. Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2011;155:762-771.
5. Bleyer A, Welch HG. Effect of 3 decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998-2005.
6. Lieberman DA. Clinical practice. Screening for colorectal cancer. N Engl J Med. 2009;361:1179-1187.
7. Lieberman D. Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology. 2010;138:2115-2126.
8. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570-1595.
9. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104:739-750.
10. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
11. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sig-moidoscopy screening in prevention of colorectal cancer: a multi-centre randomised controlled trial. Lancet. 2010;375:1624-1633.
12. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366:2345-2357.
13. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-1981.
14. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypec-tomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687-696.
15. Norwegian Department of Health and Social Affairs. The Northern-European Initiative on Colorectal Cancer (NordICC). NLM Identifier: NCT00883792. Bethesda, MD: National Library of Medicine; 2009. Available at: http://clinicaltrials.gov/show/NCT00883792. Accessed December 23, 2013.
16. Burt RW, Barthel JS, Dunn KB, et al. NCCN. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw. 2010;8:8-61.
17. Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am J Prev Med. 2009;37:8-16.
18. National Cancer Institute. Figure SCO3. Colorectal test use rates for adults aged 50 years and older by race/ethnicity: 1987-2010. In: National Cancer Institute, ed. Cancer Trends Progress Report- 2011/2012 Update. Bethesda, MD: National Cancer Institute, National Institutes of Health, Department of Health and Human Services; 2012.
19. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colo-rectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389-394.
20. Surveillance, Epidemiology, and End Results (SEER) Program. SEER∗Stat Database: Incidence-SEER 9 Registries Research Data, November 2011 submission, Vintage 2009 Populations (1973-2009) Katrina/Rita Population Adjustment-Linked to County Attributes-Total US, 1969-2010 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; released April 2012, based on the November 2011 submission.
21. Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Current Probl Cancer. 2012;36: 183-190.
22. Surveillance, Epidemiology, and End Results (SEER) Program; National Cancer Institute. US Population Data-1969-2011. Available at: http://seer.cancer.gov/popdata/2013. Accessed November 1, 2013.
23. Wang L, Wilson SE, Stewart DB, Hollenbeak CS. Marital status and colon cancer outcomes in US Surveillance, Epidemiology and End Results registries: does marriage affect cancer survival by gender and stage? Cancer Epidemiol. 2011;35:417-422.
24. Haug U, Kuntz KM, Knudsen AB, Hundt S, Brenner H. Sensitivity of immunochemical faecal occult blood testing for detecting left-vs right-sided colorectal neoplasia. Br J Cancer. 2011;104:1779-1785.
25. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U. Protection from right-and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst. 2010; 102:89-95.
26. Myer PA, Mannalithara A, Singh G, Ladabaum U. Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy. Gastroenterology. 2012;143: 1227-1236.
27. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb Mortal Wkly Rep. 2011;60:884-889.
28. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15:547-569.
29. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1-8.
30. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312: 1604-1608.
31. Chu KC, Tarone RE, Chow WH, Hankey BF, Ries LA. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst. 1994;86:997-1006.
32. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260:103-117.
33. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544-573.
34. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemio-logical evidence. Int J Cancer. 2009;125:171-180.
35. Cuzick J, Otto F, Baron JA, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol. 2009;10:501-507.
36. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colo-rectal cancer: a targeted, updated systematic review for the US Preventive Services Task Force. Ann Intern Med. 2008;149:638-658.
37. Gupta S, Balasubramanian BA, Fu T, Genta RM, Rockey DC, Lash R. Polyps with advanced neoplasia are smaller in the right than in the left colon: implications for colorectal cancer screening. Clin Gas-troenterol Hepatol. 2012;10:1395-1401, e1392.
38. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and gen-eralizability to the United States elderly population. Med Care. 2002;40(8 suppl):IV-3-IV-18.
39. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
40. Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18:1695-1698.